Traffic Lights
Satralizumab (Enspryng)
Status:
Do Not Prescribe (DNP)
Decision Date:
April 2024
Comments
NICE TA960
: For preventing relapses in neuromyelitis optica spectrum disorders. (Terminated Appraisal).
search again